Any future additional therapeutic studies for EGFR TKIs should take into consideration the possibility of SCLC transformation, and perform sub-sequential histological examinations where SCLC genomic markers may not be necessarily detected by liquid biopsy. Here, EGFR is linked to small cell lung carcinoma.